Ferede Yared Andargie, Zewdu Woretaw Sisay, Zeleke Mulugeta Molla, Alemu Muluken Adela
School of Pharmacy, College of Medicine and Health Science, Debre Tabor University, Debre Tabor, Ethiopia.
Evid Based Complement Alternat Med. 2021 Nov 27;2021:3627878. doi: 10.1155/2021/3627878. eCollection 2021.
Diarrheal disease is a major cause of morbidity and mortality throughout the world, particularly in developing countries. Currently available drugs are linked with adverse effects, contraindications, and risk of resistance. Traditionally, the leaf concoction of is claimed to be used for diarrhea. However, the safety and efficacy of the leaf extract have not been scientifically approved yet. Therefore, the study was conducted to validate its antidiarrheal activity and safety profile in mice.
The hydromethanolic extract was obtained by the cold maceration technique in 80% methanol. Phytochemical screening tests were done for secondary metabolites by using standard tests. The antidiarrheal activity of the test extract at the doses of 100, 200, and 400 mg/kg was evaluated by using castor oil-induced diarrheal, gastrointestinal transit, and enteropooling models in mice.
In an acute toxicity study, there were no visible signs of toxicity and mortality following a single oral administration of 2000 mg/kg. Phytochemical screening tests revealed the presence of alkaloids, saponins, flavonoids, terpenoids, phenols, and tannins. The hydromethanolic extract significantly prolonged the onset of diarrhea and reduced the weight of wet and total feces at 100 ( < 0.01), 200 ( < 0.001), and 400 mg/kg ( < 0.001) in the castor oil-induced diarrheal model. However, in the gastrointestinal transit model, a significant ( < 0.001) reduction in the charcoal meal travel was observed in the middle (200 mg/kg) and higher (400 mg/kg) test doses. Similarly, the extract produced a significant ( < 0.001) reduction in the weight and volume of intestinal contents at the aforementioned doses.
The study demonstrated that the test extract showed promising antidiarrheal activity. Hence, this study supports its antidiarrheal use in Ethiopian folklore medicine.
腹泻病是全球发病和死亡的主要原因,在发展中国家尤为如此。目前可用的药物存在不良反应、禁忌症和耐药风险。传统上,[植物名称]的叶煎剂据称可用于治疗腹泻。然而,叶提取物的安全性和有效性尚未得到科学验证。因此,本研究旨在验证其在小鼠中的止泻活性和安全性。
采用冷浸法在80%甲醇中获得水甲醇提取物。通过标准试验对次生代谢产物进行植物化学筛选试验。使用蓖麻油诱导的腹泻、胃肠转运和肠积液模型,评估受试提取物在100、200和400mg/kg剂量下的止泻活性。
在急性毒性研究中,单次口服2000mg/kg后未观察到明显的毒性和死亡迹象。植物化学筛选试验显示存在生物碱、皂苷、黄酮类、萜类、酚类和单宁。在蓖麻油诱导的腹泻模型中,水甲醇提取物在100(P<0.01)、200(P<0.001)和400mg/kg(P<0.001)剂量下显著延长腹泻发作时间,并减少湿粪和总粪重量。然而,在胃肠转运模型中,中等剂量(200mg/kg)和高剂量(400mg/kg)的受试提取物显著(P<0.001)减少炭末推进距离。同样,在上述剂量下,提取物显著(P<0.001)减少肠内容物的重量和体积。
该研究表明受试提取物显示出有前景的止泻活性。因此,本研究支持其在埃塞俄比亚民间医学中的止泻用途。